Primary Care Physicians' Adherence to Guidelines and Their Likelihood to Prescribe the Human Papillomavirus Vaccine for 11- and 12-Year-Old Girls.

Andrzej Kulczycki, Haiyan Qu, Richard Shewchuk
Author Information
  1. Andrzej Kulczycki: Department of Health Care Organization and Policy, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: andrzej@uab.edu.
  2. Haiyan Qu: Department of Health Services Administration, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama.
  3. Richard Shewchuk: Department of Health Services Administration, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama.

Abstract

BACKGROUND: Inadequate physician adherence to guidelines has received scant attention as a possible cause of suboptimal human papillomavirus (HPV) vaccination rates. We assessed the extent to which primary care physicians (PCPs) adhere to clinical guidelines and their reported intentions to prescribe HPV vaccine to females in the targeted age group, and how this is influenced by perceptions of guideline clarity and other factors.
METHODS: We surveyed 301 PCPs to explore their sociodemographic and practice-related characteristics, beliefs, professional norms, and perceived barriers to administer HPV vaccine. Logistic regression predicted the likelihood to prescribe HPV vaccine to 11- and 12-year-old girls on an array of variables hypothesized to influence physicians' recommendations.
RESULTS: Only 67% of PCPs reported being likely to prescribe HPV vaccine to 11- and 12-year-old patients. PCPs were more likely to prescribe vaccine to 11- and 12-year-old girls if they believed HPV vaccine guidelines were clear (odds ratio [OR], 1.85; 95% CI, 1.03-3.35), agreed with a mandate requirement (OR, 2.39; 95% CI, 1.01-5.61), felt comfortable discussing HPV vaccination with early adolescent girls (OR, 5.10; 95% CI, 2.75-9.45), and had at least 25% of their patients using public assistance to pay for their clinic visits (OR, 3.82; 95% CI, 1.91-7.34). Practice specialty (family physicians or pediatricians) and region were not significant predictors.
CONCLUSIONS: PCPs exhibit moderate levels of adherence to professional guidelines regarding HPV vaccination. Potential public health benefits will not be realized without stronger efforts to improve the rates at which PCPs administer the vaccine, particularly to 11- and 12-year-olds for whom it is preferentially recommended.

References

  1. MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):300-4 [PMID: 25811679]
  2. Am J Prev Med. 2010 May;38(5):525-33 [PMID: 20409501]
  3. Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2325-32 [PMID: 19661092]
  4. Pediatrics. 2010 Sep;126(3):425-33 [PMID: 20679306]
  5. N Engl J Med. 2010 Aug 19;363(8):785-91 [PMID: 20818883]
  6. Vaccine. 2011 Jan 10;29(3):528-34 [PMID: 21050904]
  7. Pediatrics. 2011 Jan;127(1):77-84 [PMID: 21149425]
  8. J Infect Dis. 2011 Aug 15;204(4):566-73 [PMID: 21791659]
  9. BMC Pediatr. 2011;11:74 [PMID: 21878128]
  10. Am J Prev Med. 2011 Oct;41(4):428-33 [PMID: 21961471]
  11. Pediatrics. 2011 Nov;128(5):830-9 [PMID: 22007006]
  12. Womens Health Issues. 2012 Jan-Feb;22(1):e19-26 [PMID: 21907591]
  13. Vaccine. 2012 May 21;30(24):3546-56 [PMID: 22480928]
  14. Womens Health Issues. 2012 Jul-Aug;22(4):e379-86 [PMID: 22609253]
  15. J Am Board Fam Med. 2012 Jul-Aug;25(4):496-510 [PMID: 22773718]
  16. Pediatrics. 2012 Nov;130(5):798-805 [PMID: 23071201]
  17. Vaccine. 2012 Nov 20;30 Suppl 5:F12-23 [PMID: 23199955]
  18. Am J Public Health. 2013 Jan;103(1):164-9 [PMID: 22698055]
  19. J Natl Cancer Inst. 2013 Feb 6;105(3):175-201 [PMID: 23297039]
  20. Sex Transm Dis. 2013 Mar;40(3):187-93 [PMID: 23403598]
  21. Pediatrics. 2013 Apr;131(4):645-51 [PMID: 23509163]
  22. J Infect Dis. 2013 Aug 1;208(3):385-93 [PMID: 23785124]
  23. J Adolesc Health. 2013 Dec;53(6):756-62 [PMID: 23992645]
  24. Am J Prev Med. 2014 Jan;46(1):80-4 [PMID: 24355675]
  25. JAMA Pediatr. 2014 Jan;168(1):76-82 [PMID: 24276343]
  26. Pediatrics. 2014 Mar;133(3):404-11 [PMID: 24488747]
  27. Vaccine. 2014 Mar 20;32(14):1616-23 [PMID: 23791695]
  28. Vaccine. 2014 Mar 20;32(14):1595-601 [PMID: 24606637]
  29. MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):620-4 [PMID: 25055185]
  30. MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):625-33 [PMID: 25055186]
  31. MMWR Recomm Rep. 2014 Aug 29;63(RR-05):1-30 [PMID: 25167164]
  32. Vaccine. 2014 Sep 22;32(42):5432-5 [PMID: 25131744]
  33. Pediatrics. 2014 Oct;134(4):e1049-56 [PMID: 25225141]
  34. J Adolesc Health. 2009 Nov;45(5):453-62 [PMID: 19837351]
  35. JAMA. 1999 Oct 20;282(15):1458-65 [PMID: 10535437]
  36. Am J Health Promot. 1996 Nov-Dec;11(2):87-98 [PMID: 10163601]
  37. Prev Med. 2007 Aug-Sep;45(2-3):107-14 [PMID: 17628649]
  38. Pediatrics. 2009 Jun;123(6):1439-45 [PMID: 19482752]
  39. Vaccine. 2010 Mar 16;28(13):2517-21 [PMID: 20117259]

Grants

  1. R03 AI090499/NIAID NIH HHS
  2. R03AI090499-01/NIAID NIH HHS

MeSH Term

Child
Female
Guideline Adherence
Health Care Surveys
Health Knowledge, Attitudes, Practice
Humans
Intention
Logistic Models
Male
Papillomavirus Vaccines
Physicians, Primary Care
Practice Guidelines as Topic
Practice Patterns, Physicians'
Prescriptions
Rural Population
Surveys and Questionnaires
Urban Population

Chemicals

Papillomavirus Vaccines

Word Cloud

Created with Highcharts 10.0.0HPVvaccinePCPs11-guidelinesprescribe195%CIvaccination12-year-oldgirlsORadherenceratesphysiciansreportedprofessionaladministerlikelypatients2publicBACKGROUND:InadequatephysicianreceivedscantattentionpossiblecausesuboptimalhumanpapillomavirusassessedextentprimarycareadhereclinicalintentionsfemalestargetedagegroupinfluencedperceptionsguidelineclarityfactorsMETHODS:surveyed301exploresociodemographicpractice-relatedcharacteristicsbeliefsnormsperceivedbarriersLogisticregressionpredictedlikelihoodarrayvariableshypothesizedinfluencephysicians'recommendationsRESULTS:67%believedclearoddsratio[OR]8503-335agreedmandaterequirement3901-561feltcomfortablediscussingearlyadolescent51075-945least25%usingassistancepayclinicvisits38291-734PracticespecialtyfamilypediatriciansregionsignificantpredictorsCONCLUSIONS:exhibitmoderatelevelsregardingPotentialhealthbenefitswillrealizedwithoutstrongereffortsimproveparticularly12-year-oldspreferentiallyrecommendedPrimaryCarePhysicians'AdherenceGuidelinesLikelihoodPrescribeHumanPapillomavirusVaccine12-Year-OldGirls

Similar Articles

Cited By